| Literature DB >> 33291553 |
Shengkui Zhang1, Yongbin Wang2, Ying Zhu1, Xiaoming Li1, Yang Song1, Juxiang Yuan1.
Abstract
The misalignment between the circadian clock and behavioral cycles has been implicated in pathogenesis of many diseases. The main purpose of this study is to examine the association between rotating night shift work, exposure to light at night, and glomerular filtration rate among steelworkers in north China. A total of 6869 steelworkers, aged 22 to 60 years, were included in this study. Multivariable logistic regression was used to examine the association between night shift work, the brightness of bedroom ambient light at night (LAN), and estimated glomerular filtration rate (eGFR), with adjustment for potential confounders. Mediation analysis was performed to examine the mediation effect of potential mediators on the association of duration of night shifts and eGFR. Long duration of night shift work (≥29 years) had elevated odds of decreased eGFR (≤89 mL/min/1.73 m2) (odds ratio (OR), 1.37, 95% confidence interval (CI) 1.09-1.73) compared with day work after adjustment for potential confounders. The association between duration of night shifts and eGFR (continuous) was partially modified by diastolic blood pressure (average causal mediation effect (ACME), -0.077, 95% CI -0.134 to -0.030, p < 0.001). No significant associations were observed among the different brightness of bedroom ambient light levels: middle level (OR, 0.90, 95% CI 0.77-1.05), lightest level (OR, 0.94, 95% CI 0.75-1.18), and decreased eGFR compared with the darkest level. Long-term night-shift work, rather than the brightness of bedroom ambient LAN, is associated with early stage of renal dysfunction in steelworkers, and blood pressure may mediate the relationship between night shift work and decreased eGFR.Entities:
Keywords: light at night; night shift work; renal function
Mesh:
Substances:
Year: 2020 PMID: 33291553 PMCID: PMC7730862 DOI: 10.3390/ijerph17239035
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Basic characteristics according to eGFR status.
| Variables | Overall | Non-Decreased eGFR | Decreased eGFR | |
|---|---|---|---|---|
| ( | ( | ( | ||
| Age (year), mean ± SD | 44.2 ± 8.0 | 43.6 ± 8.1 | 47.9 ± 6.3 | <0.001 |
| Sex, n (%) | ||||
| Male | 6283 (91.5) | 5370 (91.6) | 913 (90.5) | 0.226 |
| Female | 586 (8.5) | 490 (8.4) | 96 (9.5) | |
| Ethnicity, n (%) | 0.494 | |||
| Han | 6727 (97.9) | 5736 (97.9) | 991 (98.2) | |
| Others | 142 (2.1) | 124 (2.1) | 18 (1.8) | |
| BMI (kg/m2), mean ± SD | 25.2 ± 3.4 | 25.1 ± 3.4 | 25.7 ± 3.3 | <0.001 |
| Smoking status, n (%) | 0.196 | |||
| Never | 2817 (41.0) | 2409 (41.1) | 408 (40.4) | |
| Ever | 549 (8.0) | 454 (7.6) | 95 (9.4) | |
| Current | 3503 (51.0) | 2997 (51.1) | 506 (50.2) | |
| Alcohol consumption, n (%) | 0.233 | |||
| Never | 3936 (57.3) | 3353 (57.2) | 583 (57.8) | |
| Ever | 393 (5.7) | 325 (5.6) | 68 (6.7) | |
| Current | 2540 (37.0) | 2182 (37.2) | 358 (35.5) | |
| Education level, n (%) | <0.001 | |||
| Primary or illiterate | 86 (1.3) | 71 (1.2) | 15 (1.5) | |
| Middle or high school | 5326 (77.5) | 4483 (76.5) | 843 (83.6) | |
| University or college | 1457 (21.2) | 1306 (22.3) | 151 (15.0) | |
| Physical activity, n (%) | 0.270 | |||
| Low | 80 (1.2) | 70 (1.2) | 10 (1.0) | |
| Moderate | 522 (7.6) | 457 (7.8) | 65 (6.4) | |
| High | 6267 (91.2) | 5333 (91.0) | 934 (92.6) | |
| Duration of night shift work (years), n (%) | <0.001 | |||
| Day work | 1029 (15.0) | 896 (15.3) | 133 (13.2) | |
| Q1 (1–12) | 1471 (21.4) | 1317 (22.5) | 154 (15.3) | |
| Q2 (13–20) | 1495 (21.8) | 1328 (22.7) | 167 (16.6) | |
| Q3 (21–28) | 1314 (19.1) | 1102 (18.8) | 212 (21.0) | |
| Q4 (29–43) | 1560 (22.7) | 1217 (20.8) | 343 (34.0) | |
| Brightness of bedroom ambient LAN, n (%) | 0.856 | |||
| Darkest level | 3782 (55.1) | 3222 (55.0) | 560 (55.5) | |
| Middle level | 2276 (33.1) | 1949 (33.2) | 327 (32.4) | |
| Lightest level | 811 (11.8) | 689 (11.8) | 122 (12.1) | |
| Living duration of current residence, n (%) | 0.899 | |||
| <5 years | 2191 (31.9) | 1862 (31.8) | 329 (32.6) | |
| 6–10 years | 1642 (23.9) | 1400 (23.9) | 242 (24.0) | |
| 11–20 years | 1682 (24.5) | 1444 (24.6) | 238 (23.4) | |
| >20 years | 1354 (19.7) | 1154 (19.7) | 200 (19.8) | |
| Number of times light on (times/night), n (%) | 0.645 | |||
| 0 | 4194 (61.1) | 3584 (61.2) | 610 (60.5) | |
| 1 | 2172 (31.6) | 1854 (31.6) | 318 (31.5) | |
| ≥2 | 503 (7.3) | 422 (7.2) | 81 (8.0) | |
| Sleep duration (h), mean ± SD | 6.8 ± 1.2 | 6.8 ± 1.2 | 6.8 ± 1.2 | 0.005 |
| Insomnia, n (%) | 0.990 | |||
| No | 4560 (66.4) | 3890 (66.4) | 670 (66.4) | |
| Yes | 2309 (33.6) | 1970 (33.6) | 339 (33.6) | |
| Diabetes, n (%) | 0.150 | |||
| No | 6147 (89.5) | 5257 (89.7) | 890 (88.2) | |
| Yes | 722 (10.5) | 603 (10.3) | 119 (11.8) | |
| Fasting blood glucose (mmol/L), median (IQR) | 5.8 (5.4 to 6.3) | 5.8 (5.4 to 6.3) | 5.9 (5.5 to 6.4) | <0.001 |
| Hypertension, n (%) | <0.001 | |||
| No | 5109 (74.4) | 4447 (75.9) | 662 (65.6) | |
| Yes | 1760 (25.6) | 1413 (24.1) | 347 (34.4) | |
| Systolic blood pressure (mmHg), mean ± SD | 129.0 ± 16.0 | 128.5 ± 15.8 | 131.8 ± 17.2 | <0.001 |
| Diastolic blood pressure (mmHg), mean ± SD | 82.5 ± 10.4 | 82.2 ± 10.2 | 84.7 ± 11.0 | <0.001 |
| Hyperuricemia, n (%) | <0.001 | |||
| No | 4586 (66.8) | 4070 (60.5) | 516 (51.1) | |
| Yes | 2283 (33.2) | 1790 (30.6) | 493 (48.9) | |
| Serum uric acid (μmol/L), mean ± SD | 385.8 ± 94.2 | 385.3 ± 94.7 | 389.2 ± 91.1 | 0.244 |
| a Proteinuria (mg/dl), n (%) | <0.001 | |||
| A1 (<30) | 6745 (98.2) | 5772 (98.5) | 973 (96.4) | |
| A2-A3 (≥30) | 124 (1.8) | 88 (1.5) | 36 (3.6) |
Values are expressed as the mean ± standard deviation (SD) or median (interquartile range (IQR)) or number (%); p-values were from Pearson’s chi-square test for categorical variables and Student’s t-test or Wilcoxon Scores (Rank Sums) for continuous variables. a Categories of proteinuria were defined as negative and trace (proteinuria < 30 mg/dl, A1), 1+ (proteinuria: 30–300 mg/dl, A2), and 2+ (proteinuria > 300 mg/dl, A3). SD, standard deviation; IQR, interquartile range; BMI, body mass index; eGFR, estimated glomerular filtration rate.
Independent effect of night shift work and bedroom ambient light level on decreased eGFR.
| Exposure Metrics | Decreased eGFR | OR (95% CI) | |||
|---|---|---|---|---|---|
| No, n (%) | Yes, n (%) | Model 1 | Model 2 | Model 3 | |
| Duration of night shift (years) | |||||
| Day work | 896 (15.3) | 133 (13.2) | 1.00 | 1.00 | 1.00 |
| Q1 (1–12) | 1317 (22.5) | 154 (15.3) | 0.79 (0.61 to 1.01) | 1.10 (0.85 to 1.42) | 1.03 (0.79 to 1.34) |
| Q2 (13–20) | 1328 (22.7) | 167 (16.6) | 0.84 (0.66 to 1.08) | 1.12 (0.87 to 1.44) | 1.01 (0.78 to 1.31) |
| Q3 (21–28) | 1102 (18.8) | 212 (21.0) | 1.29 (1.02 to 1.63) | 1.32 (1.04 to 1.68) | 1.28 (1.01 to 1.64) |
| Q4 (29–43) | 1217 (20.8) | 343 (34.0) | 1.89 (1.52 to 2.36) | 1.40 (1.12 to 1.75) | 1.37 (1.09 to 1.73) |
| <0.001 | <0.001 | 0.001 | |||
| Brightness of bedroom ambient LAN | |||||
| Darkest level | 3222 (55.0) | 560 (55.5) | 1.00 | 1.00 | 1.00 |
| Middle level | 1949 (33.3) | 327 (32.4) | 0.96 (0.83 to 1.12) | 0.91 (0.78 to 1.06) | 0.90 (0.77 to 1.05) |
| Lightest level | 689 (11.8) | 122 (12.1) | 0.99 (0.80 to 1.23) | 0.97 (0.78 to 1.21) | 0.94 (0.75 to 1.18) |
Values are expressed as number (%) or OR (95% CI). Model 1: unadjusted; Model 2: adjusted for age and sex; Model 3: further adjusted for BMI (<25, 25–30, or ≥30 kg/m2), smoking status, drinking status, education level, sleep duration (<7 or ≥7 h), living duration of current residence, number of times light on, insomnia, diabetes, hypertension, and hyperuricemia. OR, odds ratio; CI, confidence interval; BMI, body mass index; eGFR, estimated glomerular filtration rate.
Figure 1Associations of duration of night shifts (continuous), and cumulative number of night shifts (continuous) with eGFR. “Difference in eGFR” indicates difference in eGFR (mL/min/1.73 m2), where the reference values for duration of night shifts and cumulative number of night shifts are all 0 (day work). Adjusted for age, sex, BMI (<25, 25–30, or ≥30 kg/m2), smoking status, drinking status, education level, short sleep duration (<7 or ≥7 h), living duration of current residence, number of times light on, insomnia, diabetes, hypertension, and hyperuricemia. BMI, body mass index; eGFR, estimated glomerular filtration rate; OR, odds ratio; CI, 95% confidence interval.
Associations between duration of night shifts and decreased eGFR stratified by sex, BMI, brightness of bedroom ambient LAN, diabetes, hypertension, hyperuricemia, insomnia, and short sleep duration.
| Groups | Duration of Night Shifts (Years) | |||||
|---|---|---|---|---|---|---|
| Day Work | Q1 (1–12) | Q2 (13–20) | Q3 (21–28) | Q4 (29–43) | ||
| Sex | 0.128 | |||||
| Male, OR (95% CI) | 1.00 | 0.99 (0.74 to 1.31) | 1.02 (0.78 to 1.35) | 1.36 (1.04 to 1.76) | 1.40 (1.12 to 1.79) | |
| Female, OR (95% CI) | 1.00 | 0.88 (0.40 to 1.95) | 0.65 (0.29 to 1.47) | 0.65 (0.29 to 1.47) | 0.79 (0.34 to 1.87) | |
| BMI | 0.725 | |||||
| <25, OR (95% CI) | 1.00 | 1.13 (0.77 to 1.67) | 1.23 (0.84 to 1.80) | 1.48 (1.02 to 2.13) | 1.57 (1.11 to 2.20) | |
| ≥25, OR (95% CI) | 1.00 | 0.92 (0.64 to 1.32) | 0.84 (0.59 to 1.19) | 1.11 (0.79 to 1.55) | 1.18 (0.85 to 1.63) | |
| Brightness of bedroom ambient LAN | 0.905 | |||||
| Darkest level, OR (95% CI) | 1.00 | 1.03 (0.71 to 1.49) | 1.05 (0.74 to 1.51) | 1.37 (0.97 to 1.94) | 1.45 (1.04 to 2.03) | |
| Middle or Lightest level, OR (95% CI) | 1.00 | 1.06 (0.73 to 1.54) | 1.00 (0.68 to 1.47) | 1.23 (0.86 to 1.76) | 1.32 (0.95 to 1.83) | |
| Diabetes | 0.724 | |||||
| No, OR (95% CI) | 1.00 | 0.98 (0.7 to 1.30) | 0.99 (0.76 to 1.30) | 1.26 (0.97 to 1.63) | 1.29 (1.01 to 1.66) | |
| Yes, OR (95% CI) | 1.00 | 1.56 (0.66 to 3.69) | 1.11 (0.44 to 2.82) | 1.49 (0.64 to 3.47) | 1.88 (0.91 to 3.90) | |
| Hypertension | 0.683 | |||||
| No, OR (95% CI) | 1.00 | 1.01 (0.74 to 1.38) | 0.95 (0.69 to 1.29) | 1.20 (0.89 to 1.62) | 1.38 (1.03 to 1.84) | |
| Yes, OR (95% CI) | 1.00 | 1.06 (0.65 to 1.72) | 1.21 (0.76 to 1.94) | 1.50 (0.96 to 2.32) | 1.37 (0.91 to 2.06) | |
| Hyperuricemia | 0.077 | |||||
| No, OR (95% CI) | 1.00 | 0.98 (0.68 to 1.42) | 1.28 (0.90 to 1.82) | 1.37 (0.98 to 1.91) | 1.56 (1.15 to 2.12) | |
| Yes, OR (95% CI) | 1.00 | 1.02 (0.69 to 1.49) | 0.78 (0.53 to 1.15) | 1.16 (0.80 to 1.70) | 1.13 (0.78 to 1.64) | |
| Insomnia | 0.833 | |||||
| No, OR (95% CI) | 1.00 | 0.99 (0.72 to 1.36) | 0.96 (0.70 to 1.32) | 1.21 (0.89 to 1.63) | 1.38 (1.04 to 1.84) | |
| Yes, OR (95% CI) | 1.00 | 1.11 (0.70 to 178) | 1.10 (0.70 to 1.75) | 1.41 (0.91 to 2.20) | 1.42 (0.93 to 2.15) | |
| Short sleep duration | 0.896 | |||||
| No, OR (95% CI) | 1.00 | 1.16 (0.77 to 1.74) | 1.15 (0.77 to 1.71) | 1.50 (1.03 to 2.19) | 1.49 (1.05 to 2.12) | |
| Yes, OR (95% CI) | 1.00 | 0.98 (0.69 to 1.38) | 0.92 (0.65 to 1.30) | 1.13 (0.81 to 1.59) | 1.31 (0.95 to 1.81) | |
p-values for interaction were estimated using a log likelihood ratio test to compare models with and without cross-product interaction terms. Adjusted for age, sex, BMI (<25, 25–30, or ≥30 kg/m2), smoking status, drinking status, education level, short sleep duration (<7 or ≥7 h), living duration of current residence, number of times light on, insomnia, diabetes, hypertension, and hyperuricemia (except for the stratification variable in each subgroup). OR, odds ratio; CI, confidence interval; BMI, body mass index; eGFR, estimated glomerular filtration rate.
Mediation analysis of potential mediators on the association between duration of night shifts and eGFR.
| Mediators | Effect Size (95% CI) | |
|---|---|---|
| Systolic blood pressure (mmHg) | ||
| ACME | −0.021 (−0.060 to 0.006) | 0.160 |
| ADE | −1.188 (−1.916 to −0.458) | <0.001 |
| Total effect | −1.210 (−1.924 to −0.483) | <0.001 |
| Proportion of mediation | 0.018 (−0.006 to 0.073) | 0.160 |
| Diastolic blood pressure (mmHg) | ||
| ACME | −0.077 (−0.134 to −0.030) | <0.001 |
| ADE | −1.133 (−1.851 to −0.409) | <0.001 |
| Total effect | −1.210 (−1.925 to −0.483) | <0.001 |
| Proportion of mediation | 0.064 (0.024 to 0.167) | <0.001 |
| Fasting blood glucose (mmol/L) | ||
| ACME | 0.037 (−0.021 to 0.093) | 0.200 |
| ADE | −1.231 (−1.919 to −0.504) | <0.001 |
| Total effect | −1.194 (−1.885 to −0.463) | <0.001 |
| Proportion of mediation | −0.031 (−0.113 to 0.018) | <0.001 |
| Serum uric acid (μmol/L) | ||
| ACME | −0.002 (−0.019 to 0.010) | 0.730 |
| ADE | −1.286 (−2.068 to −0.545) | 0.004 |
| Total effect | −1.288 (−2.070 to −0.548) | 0.004 |
| Proportion of mediation | 0.002 (−0.009 to 0.015) | 0.730 |
| Sleep duration (hours) | ||
| ACME | 0.031 (−0.049 to 0.112) | 0.480 |
| ADE | −1.243 (−1.893 to −0.503) | <0.001 |
| Total effect | −1.213 (−1.867 to −0.485) | <0.001 |
| Proportion of mediation | −0.025 (−0.125 to 0.045) | <0.001 |
| AIS score | ||
| ACME | −0.014 (−0.047 to 0.005) | 0.210 |
| ADE | −1.200 (−1.882 to −0.466) | <0.001 |
| Total effect | −1.214 (−1.896 to −0.489) | <0.001 |
| Proportion of mediation | 0.012 (−0.006 to 0.053) | 0.210 |
Adjusted for age, sex, BMI (<25, 25–30, or ≥30 kg/m2), smoking status, drinking status, education level, short sleep duration (<7 or ≥7 h), living duration of current residence, number of times light on, insomnia, diabetes, hypertension, and hyperuricemia (mediator was included as continuous variable in each mediation analysis). BMI, body mass index; eGFR, estimated glomerular filtration rate; AIS, Athens Insomnia Scale; ACME, average causal mediation effect; ADE, average direct effect.